Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Trend-Following Stocks
Growth stocks
ESG stocks
Undervalued stocks
Quality stocks
Momentum stocks
Investment Themes
Cybersecurity
Robotics
The SPAC
Europe's family businesses
Place your bets
The Vegan Market
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
The Vegan Market
Place your bets
Robotics
US Basketball
Hydrogen
Artificial Intelligence
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
France
Euronext Paris
Cellectis S.A.
News
Summary
ALCLS
FR0010425595
CELLECTIS S.A.
(ALCLS)
Add to my list
Report
Real-time Euronext Paris -
05/27 11:35:29 am EDT
3.614
EUR
+4.75%
05/26
European ADRs Move Higher in Thursday Trading
MT
05/25
European ADRs Move Lower in Wednesday Trading
MT
05/24
Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
European ADRs Move Lower in Friday Trading
01/21/2022 | 11:11am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
AKARI THERAPEUTICS, PLC
-3.69%
1.175
-18.67%
ARCELORMITTAL
3.24%
30.445
4.78%
AVADEL PHARMACEUTICALS PLC
130.07%
2.4611
-86.76%
BHP GROUP LIMITED
2.46%
43.67
2.70%
BIOFRONTERA AG
0.90%
1.125
-24.66%
BIONTECH SE
4.45%
164.9
-38.65%
BRITISH AMERICAN TOBACCO PLC
-0.39%
3550.5
30.40%
CELLECTIS S.A.
4.75%
3.614
-53.63%
EDAP TMS S.A.
-0.63%
7.095
19.20%
MEREO BIOPHARMA GROUP PLC
8.58%
0.5201
-70.06%
NATUZZI S.P.A.
-2.05%
9.57
-39.92%
NUCANA PLC
-2.50%
0.6045
-73.95%
TRINITY BIOTECH PLC
3.42%
1.4272
-3.50%
UNILEVER PLC
-0.36%
3475.5
-11.60%
VIA OPTRONICS AG
-0.19%
2.5
-65.92%
All news about CELLECTIS S.A.
05/26
European ADRs Move Higher in Thursday Trading
MT
05/25
European ADRs Move Lower in Wednesday Trading
MT
05/24
Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
05/24
Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23
CELLECTIS S A
: ' Annual Shareholders' General Meeting to be Held on June 28, 2022 - Form ..
PU
05/23
Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
GL
05/23
Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23
CELLECTIS S A
: Consolidated Financial Statements - Form 6-K
PU
05/20
CALYXT, INC.
: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand..
AQ
05/20
European ADRs Move Sharply Higher in Friday Trading
MT
More news
Analyst Recommendations on CELLECTIS S.A.
05/24
Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
05/18
Baird Upgrades Cellectis to Outperform From Neutral
MT
05/13
Barclays Lowers Cellectis S.A's Price Target to $7 From $9, Overweight Rating Maintaine..
MT
More recommendations
Financials
EUR
USD
Sales 2022
66,3 M
71,1 M
71,1 M
Net income 2022
-83,2 M
-89,1 M
-89,1 M
Net cash 2022
41,5 M
44,4 M
44,4 M
P/E ratio 2022
-1,56x
Yield 2022
-
Capitalization
157 M
168 M
168 M
EV / Sales 2022
1,74x
EV / Sales 2023
-1,28x
Nbr of Employees
297
Free-Float
84,3%
More Financials
Chart CELLECTIS S.A.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short Term
Mid-Term
Long Term
Trends
Neutral
Bearish
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3,45 €
Average target price
16,00 €
Spread / Average Target
364%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
André Choulika
Chief Executive Officer & Director
Bing C. Wang
Chief Financial Officer
Jean-Pierre Garnier
Non-Executive Chairman
Philippe Duchateau
Chief Scientific Officer
Carrie Brownstein
Chief Medical Officer
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
CELLECTIS S.A.
-53.63%
168
MODERNA, INC.
-46.53%
54 016
LONZA GROUP AG
-28.07%
42 292
IQVIA HOLDINGS INC.
-26.37%
39 319
SEAGEN INC.
-10.44%
25 487
ICON PUBLIC LIMITED COMPANY
-29.73%
17 693
More Results
Slave